Opaleye Management »

Nyxoah Sa Npv Isin Be0974358906 Sedol Bn782g7 shares owned by Opaleye Management

Quarter-by-quarter ownership of Nyxoah Sa Npv Isin Be0974358906 Sedol Bn782g7 (NYXH) shares owned by Opaleye Management from 13F filings

Historical chart of Opaleye Management investment in Nyxoah Sa Npv Isin Be0974358906 Sedol Bn782g7

Tip: Access up to 7 years of quarterly data

All positions including Nyxoah Sa Npv Isin Be0974358906 Sedol Bn782g7 held by Opaleye Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nyxoah Sa Npv Isin Be0974358906 Sedol Bn782g7 by Opaleye Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.6M 345k 4.64
2023-09-30 $3.1M 442k 7.05
2023-06-30 $3.6M 445k 8.01
2023-03-31 $430k 58k 7.47

More positions owned by Opaleye Management

Harrow Health (HROW)
Tg Therapeutics (TGTX)
Acelyrin (SLRN)
Rhythm Pharmaceuticals (RYTM)
Ocular Therapeutix (OCUL)
Catalyst Pharmaceutical Partners (CPRX)
Keros Therapeutics (KROS)
Ideaya Biosciences (IDYA)
Eton Pharmaceuticals (ETON)
Crinetics Pharmaceuticals In (CRNX)
Arvinas Ord (ARVN)
Codexis (CDXS)
Biohaven (BHVN)
Edgewise Therapeutics (EWTX)
Iovance Biotherapeutics (IOVA)

View all positions for Opaleye Management

Top funds holding Nyxoah Sa Npv Isin Be0974358906 Sedol Bn782g7

Opaleye Management
Deerfield Management Company
Rossmore Private Capital
DekaBank Deutsche Girozentrale
Goldman Sachs Group
Citigroup
Barclays
Bank of America Corporation
UBS Group
Wells Fargo & Company

View all funds holding Nyxoah Sa Npv Isin Be0974358906 Sedol Bn782g7